An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Steve Christo-Corbis/Getty Images Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition. By Dani Blum I’ve reported on Ozempic since 2022. New research shows ...

In a late-stage clinical trial, Wegovy (semaglutide) significantly reduced liver inflammation and reversed scarring in people with the liver disease MASH. MASH is associated with obesity and type ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.